Status:
ENROLLING_BY_INVITATION
Virtual Reality-Augmented At-Home tDCS for Major Depression
Lead Sponsor:
Technical University of Munich
Conditions:
Major Depression Moderate
Major Depression Severe
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to investigate the efficacy of combining Virtual Reality (VR)-based relaxation and Transcranial Direct Current Stimulation (tDCS) for treating Major Depression. The...
Detailed Description
Participant Recruitment: Patients with unipolar or bipolar depression will be recruited from inpatient wards at Klinikum rechts der Isar and outpatient services. After screening for eligibility and o...
Eligibility Criteria
Inclusion
- At least a moderate depressive episode (MADRS baseline score ≥ 20).
- Patients aged between 18 and 65 years.
- Sufficient cognitive abilities to understand study requirements and instructions (MMSE ≥ 27).
- Stable antidepressant/psychiatric medication for at least two weeks prior to study entry.
Exclusion
- Currently clinically relevant Axis II disorders.
- Other relevant Axis I disorders (except anxiety disorders).
- Substance use disorders within the last 3 months prior to study entry (excluding nicotine and caffeine dependence).
- Skin lesions at the site of tDCS electrode placement.
Key Trial Info
Start Date :
July 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT07146269
Start Date
July 15 2025
End Date
August 1 2026
Last Update
August 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Technical University of Munich, TUM School of Medicine and Health, Department of Psychiatry and Psychotherapy
Munich, Germany